Cargando…
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
Therapeutics against coronavirus disease 2019 (COVID-19) are urgently needed. Granulocyte–macrophage colony-stimulating factor (GM-CSF), a myelopoietic growth factor and pro-inflammatory cytokine, plays a critical role in alveolar macrophage homeostasis, lung inflammation and immunological disease....
Autores principales: | Lang, Frederick M., Lee, Kevin M.-C., Teijaro, John R., Becher, Burkhard, Hamilton, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309428/ https://www.ncbi.nlm.nih.gov/pubmed/32576980 http://dx.doi.org/10.1038/s41577-020-0357-7 |
Ejemplares similares
-
GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019) -
Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines
por: Li, Jianhua, et al.
Publicado: (2021) -
GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019) -
GM-CSF: A Promising Target in Inflammation and Autoimmunity
por: Lee, Kevin M C, et al.
Publicado: (2020) -
The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes
por: Anzai, Atsushi, et al.
Publicado: (2017)